These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8925751)

  • 1. [Methylene blue in ifosfamide-induced encephalopathy].
    Koschuth A; Späth-Schwalbe PE; Possinger K
    Dtsch Med Wochenschr; 1996 Sep; 121(39):1210. PubMed ID: 8925751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].
    Demandt M; Wandt H
    Dtsch Med Wochenschr; 1996 Apr; 121(17):575. PubMed ID: 8620831
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
    Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
    Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of ifosfamide induced encephalopathy with methylene-blue].
    Ferrero JM; Eftekari P; Largillier R; Dreyfus G; Namer M
    Bull Cancer; 1995 Jul; 82(7):598-9. PubMed ID: 7549123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue for ifosfamide-associated encephalopathy.
    Zulian GB; Tullen E; Maton B
    N Engl J Med; 1995 May; 332(18):1239-40. PubMed ID: 7700329
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
    Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
    Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
    Yeo KK; HaDuong JH
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):489-90. PubMed ID: 26907647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?
    Abahssain H; Moukafih B; Essangri H; Mrabti H; Meddah B; Guessous F; Fadhil FZ; Souadka A; Errihani H
    J Oncol Pharm Pract; 2021 Jan; 27(1):143-149. PubMed ID: 33153383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
    Küpfer A; Aeschlimann C; Cerny T
    Eur J Clin Pharmacol; 1996; 50(4):249-52. PubMed ID: 8803513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.
    McDonnell AM; Rybak I; Wadleigh M; Fisher DC
    J Oncol Pharm Pract; 2012 Dec; 18(4):436-9. PubMed ID: 22235061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ifosfamide encephalopathy with intravenous thiamin.
    Buesa JM; García-Teijido P; Losa R; Fra J
    Clin Cancer Res; 2003 Oct; 9(12):4636-7. PubMed ID: 14555540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ifosfamide induced encephalopathy: 15 observations].
    Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
    Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide encephalopathy and methylene-blue: a case report.
    Alonso JL; Nieto Y; López JA; Martín M; Díaz-Rubio E
    Ann Oncol; 1996 Aug; 7(6):643-4. PubMed ID: 8879383
    [No Abstract]   [Full Text] [Related]  

  • 14. Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma.
    Jain S; Moger V; Kumari S; Varma S
    Neurol India; 2001 Dec; 49(4):416. PubMed ID: 11799423
    [No Abstract]   [Full Text] [Related]  

  • 15. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
    Liu YL; Tsai SH; Chang FW; Yu MH
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
    Sweiss KI; Beri R; Shord SS
    Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green urine secondary to methylene blue.
    Miri-Aliabad G
    Indian J Pediatr; 2014 Nov; 81(11):1255-6. PubMed ID: 24794328
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating risk factors for the development of ifosfamide encephalopathy.
    David KA; Picus J
    Am J Clin Oncol; 2005 Jun; 28(3):277-80. PubMed ID: 15923801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide-induced Encephalopathy With Rapid Response to Thiamine: A Pediatric Case.
    Müngen E; Yaman Bajin İ; Öz S; Günbey C; Anlar B; Aydin B
    J Pediatr Hematol Oncol; 2022 Oct; 44(7):402-404. PubMed ID: 35536996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue for management of Ifosfamide-induced encephalopathy.
    Patel PN
    Ann Pharmacother; 2006 Feb; 40(2):299-303. PubMed ID: 16391008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.